Aspire Pharma Ltd: UK Public Sector Contracts Won & Awards

Companies House: Private Limited CompanyPetersfieldNationwide (UK)Main market: Pharmaceutical products

Official UK PPONPTGN-7745-MBJPCompanies House06828501 ↗ · Active

Where they win
i

72 awards (72 for a named lot, 100%, 0 for a whole procedure with no lot named) · top CPV classes, shares of all 72 awards. An award may cover more than one class.

3360 Pharmaceutical products70 awards · 97% · awards naming a lot
3369 Various medicinal products2 awards · 3% · awards naming a lot
Attributable award value
i
£3.3mOn 6 of 72 award records; the five largest make 98%. Largest rows below.
Typical attributable award
i
£280k middle valuerobust · n=6

Where their buyers are
i

ITL1 region of the buyer office · known for 60 of 60 awarded procedures · each procedure counts once

Greater London28 procedures · 47%
Scotland13 procedures · 22%
Wales (Cymru)8 procedures · 13%
North West England5 procedures · 8%
South East England3 procedures · 5%
Northern Ireland2 procedures · 3%
Yorkshire and the Humber1 procedure · 2%

Bidding record
i

Procurement Act 2023 award notices name every bidder · 5 notices name this supplier, covering 9 lots since 22 Dec 2025 · observed bids, not an estimate

Contract lots contested
i
0 won · 0 lostFewer than three decided lots: no rate is claimed.
Framework / DPS places
i
7 of 9Lots on 5 notices: a place is won per lot.
Authorities bid for
i
1
NoticeAuthorityOutcomeBiddersPublished
NHS National Generic Pharmaceuticals - Wave 16aframework/DPSNHS Englandappointedall 2 lots bid for1259 Oct 2026
NHS National Generics Pharmaceuticals - Supply Chain Resilienceframework/DPSNHS Englandappointedall 2 lots bid for416 Jul 2026
NHS National Branded Interim - 1 June 2026framework/DPSNHS Englandappointed5322 May 2026
NHS National Generic Pharmaceuticals - Wave 15cframework/DPSNHS Englandappointedall 2 lots bid for11826 Feb 2026
NHS National Framework for Generics Housekeepingframework/DPSNHS Englandnot appointed5322 Dec 2025

Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.

Who they sell to
i

Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier

Authority type · official UK type when published, else name/id class, else not classified · by award records (a single panel can dominate)
i
  • NHS & health92%(66 awards)
    66 of 72 awards are NHS & health (92%).
  • Type not classified8%(6 awards)
    6 of 72 awards are Type not classified (8%).
AuthorityProceduresShareAward recordsLast activity
NHS Englandframework/DPS on 232846.7%3827 Aug 2026
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")framework/DPS on 131321.7%199 Apr 2026
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)711.7%717 Sept 2026
The NHS Commissioning Board (operating under the name of NHS England)framework/DPS on 558.3%1330 Nov 2021
ATAMIS LTD35%37 Jul 2023
Business Services Organisation Procurement and Logistics Serviceframework/DPS on 223.3%523 Jun 2026
eTenderwales11.7%117 Jun 2025
MERCELL UK LTD11.7%130 Jun 2021

Share = of the 60 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.

Contracts ending
i

72 of 87 awards carry an end date, 24 estimated from the duration · not a retender forecast

ContractEndsPublished value
Range of Generic Cancer Medicines (single supplier)3 Jan 2027 estimated£3,432,063 ceiling
Generic Drugs - Tablets & Capsules31 Jan 2027£427,243
Wave 15a - Hospital Only Products (DNW & DLN regions)31 Jan 2027£1 ceiling
Hospital Only Products31 Jan 2027£1 ceiling
NHS National Framework - Generics Housekeeping/Supply Chain Resilience Products31 May 2027£11,656,086 ceiling
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)31 May 2027Not published
Wave 14c - Orals (plus non-parenteral) Products (all regions)31 May 2027£1 ceiling
Wave 15a - Orals (plus non-parenteral) Products (all regions)31 May 2027£1 ceiling
Medicinal Products - Direct to Trust2 Jun 2027 estimated£210,000,000 ceiling
Medicinal Products - with Pharma Funded Homecare Services2 Jun 2027 estimated£174,000,000 ceiling

Soonest 10 of 19.

Recent awards

Latest 30 of 72 award records naming this supplier

Contracts Finder adds 15 more procedures won by this supplier, mostly below the Find a Tender threshold or from before 2025. Each is counted once beside any Find a Tender copy; they are in the totals, not in this list.

Award / procedureAuthorityAwardedPublished value
Hospital Only ProductsNHS EnglandNot published£1 †
framework ceiling · not attributable revenue
NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
Range of Generic Cancer Medicines (single supplier)The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£3,432,063 †
framework ceiling · 1 of 24 appointed suppliers
Wave 15a - Hospital Only Products (Housekeeping) (DLS, DNE, DCE, DSW regions)NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
Wave 15a - Hospital Only Products (DNW & DLN regions)NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
Wave 15a - Orals (plus non-parenteral) Products (all regions)NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
ENT, Ophthalmology & Skin Generic Medicines/Medical DevicesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£9,647,464 †
framework ceiling · 1 of 31 appointed suppliers
Artificial saliva products, Eye preparations & Skin creamsThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£1,191,048 †
framework ceiling · 1 of 15 appointed suppliers
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
Dimethyl fumarate, Teriflunomide, TrabectedinNHS EnglandNot published£1 †
framework ceiling · not attributable revenue
About this data
  • One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
  • Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
  • Regions in the buyer chart describe the buyer office, not where the work is delivered or the supplier’s registered address.
  • Contract end dates. Published on 48 of 87 awards, estimated from the published duration on 24 more (marked “estimated”); those feed “Contracts ending”. Published values in that list come from either source; Contracts Finder figures are shown as published and stay out of this profile’s money totals.
  • Source. Official UK public procurement notices (Find a Tender and Contracts Finder), reused under the Open Government Licence v3.0, updated through the day and rebuilt nightly. Not every figure uses both feeds, and each one shows how many records it rests on: see the methodology. Spotted something wrong? Tell us.